Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
AZNAstraZeneca PLC DR | 198.8 B USD | 65.35 USD | +1.41% | 9.08 M | 1.55 | 31.40 | 2.08 USD | +10.04% | 2.23% | Health technology | Buy |
AMGNAmgen Inc. | 141.58 B USD | 263.38 USD | +0.84% | 13.69 M | 3.56 | 33.72 | 7.81 USD | −44.46% | 3.42% | Health technology | Buy |
SNYSanofi DR | 118.67 B USD | 47.71 USD | +0.44% | 2.49 M | 0.86 | 26.30 | 1.81 USD | −49.14% | 3.10% | Health technology | Buy |
GILDGilead Sciences, Inc. | 115.37 B USD | 92.57 USD | +1.62% | 22.53 M | 3.31 | 1,043.63 | 0.09 USD | −98.10% | 3.31% | Health technology | Buy |
VRTXVertex Pharmaceuticals Incorporated | 102.31 B USD | 397.27 USD | +0.16% | 6.2 M | 3.24 | — | −1.99 USD | −114.96% | 0.00% | Health technology | Buy |
REGNRegeneron Pharmaceuticals, Inc. | 77.13 B USD | 701.85 USD | −0.90% | 1.89 M | 2.00 | 17.37 | 40.41 USD | +15.25% | 0.00% | Health technology | Buy |
ARGXargenx SE DR | 37.81 B USD | 623.82 USD | −0.35% | 313.19 K | 1.11 | — | −3.50 USD | +51.16% | 0.00% | Health technology | Strong buy |
ALNYAlnylam Pharmaceuticals, Inc. | 31.66 B USD | 245.44 USD | +2.75% | 1.66 M | 2.68 | — | −2.62 USD | +36.82% | 0.00% | Health technology | Buy |
BNTXBioNTech SE DR | 27.11 B USD | 113.08 USD | +1.56% | 924.9 K | 1.24 | — | −2.15 USD | −118.72% | 0.00% | Health technology | Buy |
ILMNIllumina, Inc. | 21.57 B USD | 136.02 USD | +1.51% | 14.35 M | 8.12 | — | −10.00 USD | −40.39% | 0.00% | Health technology | Buy |
BIIBBiogen Inc. | 21.34 B USD | 146.47 USD | −0.62% | 5.78 M | 3.91 | 13.23 | 11.07 USD | +10.06% | 0.00% | Health technology | Buy |
BGNEBeiGene, Ltd. DR | 19.64 B USD | 176.50 USD | +1.02% | 368.47 K | 0.71 | — | −8.24 USD | +11.11% | 0.00% | Health technology | Strong buy |
UTHRUnited Therapeutics Corporation | 16.05 B USD | 359.58 USD | −0.16% | 1.01 M | 3.35 | 15.79 | 22.77 USD | +25.44% | 0.00% | Health technology | Buy |
MRNAModerna, Inc. | 15.16 B USD | 39.39 USD | −0.43% | 35.48 M | 4.89 | — | −5.82 USD | +37.62% | 0.00% | Health technology | Neutral |
VTRSViatris Inc. | 14.94 B USD | 12.52 USD | +3.22% | 56.55 M | 7.22 | — | −0.74 USD | −148.99% | 3.83% | Health technology | Neutral |
RPRXRoyalty Pharma plc | 14.68 B USD | 24.92 USD | +2.64% | 7.57 M | 2.24 | 9.75 | 2.56 USD | +538.81% | 3.37% | Health technology | Strong buy |
NBIXNeurocrine Biosciences, Inc. | 13.71 B USD | 135.42 USD | +0.34% | 2.27 M | 2.17 | 36.28 | 3.73 USD | +99.71% | 0.00% | Health technology | Strong buy |
GMABGenmab A/S DR | 13.34 B USD | 20.31 USD | +1.10% | 1.83 M | 1.57 | 19.56 | 1.04 USD | +10.05% | 0.00% | Health technology | Buy |
INCYIncyte Corporation | 13.26 B USD | 68.84 USD | +2.65% | 6.81 M | 3.62 | 487.54 | 0.14 USD | −92.50% | 0.00% | Health technology | Buy |
SMMTSummit Therapeutics Inc. | 13.18 B USD | 17.87 USD | −2.88% | 7.1 M | 3.56 | — | −0.28 USD | +82.45% | 0.00% | Health technology | Strong buy |
INSMInsmed Incorporated | 12.6 B USD | 70.44 USD | +1.48% | 5.93 M | 3.13 | — | −5.56 USD | −5.41% | 0.00% | Health technology | Strong buy |
BMRNBioMarin Pharmaceutical Inc. | 12.51 B USD | 65.66 USD | +1.02% | 3.97 M | 3.12 | 39.54 | 1.66 USD | +117.47% | 0.00% | Health technology | Buy |
SRPTSarepta Therapeutics, Inc. | 11.36 B USD | 118.97 USD | −0.42% | 1.95 M | 2.79 | 98.83 | 1.20 USD | — | 0.00% | Health technology | Strong buy |
PCVXVaxcyte, Inc. | 10.78 B USD | 86.53 USD | +0.37% | 3.89 M | 3.92 | — | −4.68 USD | −40.18% | 0.00% | Health technology | Strong buy |
MEDPMedpace Holdings, Inc. | 10.48 B USD | 337.28 USD | +0.64% | 683.33 K | 2.53 | 29.53 | 11.42 USD | +33.83% | 0.00% | Commercial services | Buy |
EXELExelixis, Inc. | 9.51 B USD | 33.29 USD | −1.16% | 7.65 M | 4.05 | 21.21 | 1.57 USD | +459.23% | 0.00% | Health technology | Buy |
ITCIIntra-Cellular Therapies Inc. | 8.85 B USD | 83.45 USD | −0.82% | 1.12 M | 2.22 | — | −0.86 USD | +47.14% | 0.00% | Health technology | Strong buy |
ROIVRoivant Sciences Ltd. | 8.42 B USD | 11.57 USD | +0.61% | 16 M | 3.66 | 2.05 | 5.66 USD | — | 0.00% | Health technology | Strong buy |
ASNDAscendis Pharma A/S DR | 8.15 B USD | 136.38 USD | −0.99% | 690.27 K | 1.55 | — | −8.10 USD | +28.89% | 0.00% | Health technology | Strong buy |
RVMDRevolution Medicines, Inc. | 8.03 B USD | 44.06 USD | +1.78% | 2.67 M | 1.63 | — | −3.59 USD | −10.04% | 0.00% | Health technology | Strong buy |
JAZZJazz Pharmaceuticals plc | 7.43 B USD | 122.97 USD | +0.10% | 1.77 M | 2.72 | 17.71 | 6.94 USD | +1,051.97% | 0.00% | Health technology | Strong buy |
MDGLMadrigal Pharmaceuticals, Inc. | 6.73 B USD | 308.44 USD | +5.12% | 716.86 K | 2.19 | — | −25.07 USD | −30.31% | 0.00% | Health technology | Strong buy |
LEGNLegend Biotech Corporation DR | 6.25 B USD | 34.08 USD | +0.18% | 1.64 M | 1.01 | — | −1.91 USD | +35.99% | 0.00% | Health technology | Strong buy |
NUVLNuvalent, Inc. | 5.98 B USD | 84.22 USD | −0.50% | 1.11 M | 2.27 | — | −3.48 USD | −71.14% | 0.00% | Health technology | Strong buy |
HALOHalozyme Therapeutics, Inc. | 5.97 B USD | 46.96 USD | −0.76% | 4.79 M | 3.65 | 15.54 | 3.02 USD | +61.29% | 0.00% | Health technology | Buy |
GRFSGrifols, S.A. DR | 5.95 B USD | 7.51 USD | −2.72% | 1.8 M | 1.98 | — | — | — | 0.00% | Health technology | Neutral |
CYTKCytokinetics, Incorporated | 5.77 B USD | 48.87 USD | +4.56% | 3.81 M | 3.63 | — | −5.39 USD | +2.40% | 0.00% | Health technology | Buy |
BPMCBlueprint Medicines Corporation | 5.73 B USD | 90.14 USD | +1.36% | 1.27 M | 1.80 | — | −2.11 USD | +77.09% | 0.00% | Health technology | Buy |
IONSIonis Pharmaceuticals, Inc. | 5.63 B USD | 35.63 USD | +0.11% | 4.06 M | 2.48 | — | −2.44 USD | +14.63% | 0.00% | Health technology | Buy |
BBIOBridgeBio Pharma, Inc. | 5.01 B USD | 26.49 USD | +1.07% | 4.2 M | 2.18 | — | −2.41 USD | +38.26% | 0.00% | Health technology | Strong buy |
CRNXCrinetics Pharmaceuticals, Inc. | 4.97 B USD | 53.60 USD | +1.63% | 1.94 M | 2.32 | — | −3.72 USD | −2.14% | 0.00% | Health technology | Strong buy |
ALKSAlkermes plc | 4.81 B USD | 29.71 USD | −0.87% | 4.64 M | 2.63 | 15.13 | 1.96 USD | +59.05% | 0.00% | Health technology | Buy |
KRYSKrystal Biotech, Inc. | 4.74 B USD | 164.83 USD | +2.49% | 898.32 K | 2.76 | 93.25 | 1.77 USD | — | 0.00% | Health technology | Strong buy |
AXSMAxsome Therapeutics, Inc. | 4.4 B USD | 90.73 USD | +1.10% | 956.38 K | 1.95 | — | −6.54 USD | −44.44% | 0.00% | Health technology | Strong buy |
SRRKScholar Rock Holding Corporation | 4.19 B USD | 44.78 USD | +6.39% | 2.88 M | 3.09 | — | −2.47 USD | −9.56% | 0.00% | Health technology | Strong buy |
APLSApellis Pharmaceuticals, Inc. | 4.13 B USD | 33.21 USD | +0.21% | 3.73 M | 1.20 | — | −2.04 USD | +61.20% | 0.00% | Health technology | Buy |
ADMAADMA Biologics Inc | 4.11 B USD | 17.40 USD | −2.79% | 6.94 M | 3.08 | 62.98 | 0.28 USD | — | 0.00% | Health technology | Strong buy |
ACLXArcellx, Inc. | 4.08 B USD | 75.54 USD | +0.44% | 1.37 M | 1.90 | — | −0.75 USD | +73.14% | 0.00% | Health technology | Strong buy |
RAREUltragenyx Pharmaceutical Inc. | 4.08 B USD | 44.22 USD | +1.73% | 1.73 M | 2.01 | — | −6.46 USD | +28.02% | 0.00% | Health technology | Strong buy |
GHGuardant Health, Inc. | 3.91 B USD | 31.67 USD | +1.73% | 2.41 M | 1.62 | — | −4.24 USD | −4.21% | 0.00% | Health services | Strong buy |
RNAAvidity Biosciences, Inc. | 3.8 B USD | 31.82 USD | +2.48% | 2.93 M | 2.05 | — | −2.90 USD | +3.08% | 0.00% | Health technology | Strong buy |
IMVTImmunovant, Inc. | 3.8 B USD | 25.86 USD | +0.78% | 3.24 M | 3.44 | — | −2.22 USD | −12.81% | 0.00% | Health technology | Strong buy |
PTCTPTC Therapeutics, Inc. | 3.57 B USD | 46.24 USD | +2.19% | 1.43 M | 2.28 | — | −5.94 USD | +31.43% | 0.00% | Health technology | Buy |
CRSPCRISPR Therapeutics AG | 3.48 B USD | 40.72 USD | +0.83% | 3.35 M | 1.70 | — | −2.82 USD | +36.99% | 0.00% | Health technology | Buy |
RYTMRhythm Pharmaceuticals, Inc. | 3.45 B USD | 56.12 USD | +1.15% | 1.52 M | 3.24 | — | −4.34 USD | −33.11% | 0.00% | Health technology | Strong buy |
VRNAVerona Pharma plc DR | 3.44 B USD | 42.02 USD | +1.94% | 733.7 K | 0.91 | — | −1.94 USD | −197.56% | 0.00% | Health technology | Strong buy |
NVCRNovoCure Limited | 3.33 B USD | 30.80 USD | +1.32% | 1.82 M | 1.42 | — | −1.39 USD | +25.11% | 0.00% | Health technology | Buy |
JANXJanux Therapeutics, Inc. | 3.28 B USD | 56.83 USD | +0.14% | 1.25 M | 1.22 | — | −1.18 USD | +20.33% | 0.00% | Health technology | Strong buy |
VCYTVeracyte, Inc. | 3.17 B USD | 40.89 USD | +4.66% | 2.01 M | 2.82 | — | −0.14 USD | +79.01% | 0.00% | Health technology | Buy |
DNLIDenali Therapeutics Inc. | 3.09 B USD | 21.45 USD | −0.19% | 2.81 M | 3.08 | — | −2.76 USD | −185.82% | 0.00% | Health technology | Strong buy |
XENEXenon Pharmaceuticals Inc. | 2.95 B USD | 38.63 USD | −0.69% | 1.11 M | 2.81 | — | −2.81 USD | −5.62% | 0.00% | Health technology | Strong buy |
FOLDAmicus Therapeutics, Inc. | 2.93 B USD | 9.80 USD | +0.72% | 4.08 M | 1.12 | — | −0.35 USD | +41.95% | 0.00% | Health technology | Strong buy |
EWTXEdgewise Therapeutics, Inc. | 2.91 B USD | 30.78 USD | −0.06% | 1.11 M | 0.97 | — | −1.49 USD | −5.64% | 0.00% | Health technology | Strong buy |
ZLABZai Lab Limited DR | 2.89 B USD | 26.72 USD | +1.91% | 392.22 K | 0.54 | — | −2.78 USD | +10.91% | 0.00% | Health technology | Strong buy |
MRUSMerus N.V. | 2.87 B USD | 41.85 USD | −0.57% | 937.3 K | 1.38 | — | −3.91 USD | −5.06% | 0.00% | Health technology | Strong buy |
TWSTTwist Bioscience Corporation | 2.85 B USD | 47.94 USD | +9.90% | 2.28 M | 2.83 | — | −3.60 USD | −0.07% | 0.00% | Health technology | Buy |
ACADACADIA Pharmaceuticals Inc. | 2.81 B USD | 16.87 USD | +0.84% | 4.94 M | 2.78 | 21.84 | 0.77 USD | — | 0.00% | Health technology | Buy |
APGEApogee Therapeutics, Inc. | 2.79 B USD | 47.71 USD | +1.47% | 606.24 K | 1.01 | — | −2.73 USD | — | 0.00% | Health technology | Strong buy |
VCELVericel Corporation | 2.79 B USD | 56.50 USD | +2.82% | 720.65 K | 1.94 | 904.00 | 0.06 USD | — | 0.00% | Health technology | Strong buy |
VERAVera Therapeutics, Inc. | 2.7 B USD | 42.60 USD | +1.31% | 2.23 M | 4.95 | — | −2.60 USD | +9.55% | 0.00% | Health technology | Strong buy |
SWTXSpringWorks Therapeutics, Inc. | 2.65 B USD | 35.59 USD | +2.33% | 1.26 M | 1.09 | — | −3.73 USD | +23.69% | 0.00% | Health technology | Strong buy |
KYMRKymera Therapeutics, Inc. | 2.63 B USD | 40.66 USD | +3.88% | 1.15 M | 2.21 | — | −2.33 USD | +19.04% | 0.00% | Health technology | Strong buy |
HCMHUTCHMED (China) Limited DR | 2.48 B USD | 14.31 USD | −2.05% | 81.47 K | 1.06 | — | −0.25 USD | −16.10% | 0.00% | Health technology | Strong buy |
PTGXProtagonist Therapeutics, Inc. | 2.47 B USD | 41.49 USD | +4.93% | 2.37 M | 3.96 | 15.56 | 2.67 USD | — | 0.00% | Health technology | Strong buy |
DYNDyne Therapeutics, Inc. | 2.44 B USD | 23.99 USD | −1.28% | 1.46 M | 1.74 | — | −3.56 USD | +0.90% | 0.00% | Health technology | Strong buy |
ARWRArrowhead Pharmaceuticals, Inc. | 2.42 B USD | 19.45 USD | −0.26% | 4.01 M | 3.07 | — | −5.00 USD | −159.88% | 0.00% | Health technology | Buy |
BEAMBeam Therapeutics Inc. | 2.4 B USD | 29.01 USD | +8.04% | 2.74 M | 1.96 | — | −1.76 USD | +57.86% | 0.00% | Health technology | Buy |
RXRXRecursion Pharmaceuticals, Inc. | 2.36 B USD | 6.03 USD | −0.99% | 19.94 M | 1.05 | — | −1.53 USD | −4.26% | 0.00% | Health technology | Buy |
CNTACentessa Pharmaceuticals plc DR | 2.26 B USD | 17.16 USD | −2.22% | 791.27 K | 1.02 | — | −1.53 USD | +7.72% | 0.00% | Health technology | Strong buy |
IOVAIovance Biotherapeutics, Inc. | 2.25 B USD | 7.38 USD | +2.22% | 11.18 M | 2.02 | — | −1.50 USD | +28.07% | 0.00% | Health technology | Strong buy |
IDYAIDEAYA Biosciences, Inc. | 2.21 B USD | 25.61 USD | +3.31% | 2.02 M | 2.54 | — | −2.33 USD | −19.54% | 0.00% | Health technology | Strong buy |
LGNDLigand Pharmaceuticals Incorporated | 2.17 B USD | 114.64 USD | +0.61% | 551.6 K | 4.59 | 45.61 | 2.51 USD | +200.39% | 0.00% | Health technology | Strong buy |
GERNGeron Corporation | 2.11 B USD | 3.49 USD | −4.64% | 26.32 M | 3.32 | — | −0.32 USD | +5.76% | 0.00% | Health technology | Strong buy |
WVEWave Life Sciences Ltd. | 2.06 B USD | 13.51 USD | +2.43% | 4.46 M | 4.52 | — | −1.11 USD | −28.14% | 0.00% | Health technology | Strong buy |
AKROAkero Therapeutics, Inc. | 2.05 B USD | 29.34 USD | +3.31% | 1.56 M | 2.87 | — | −3.75 USD | −59.03% | 0.00% | Health technology | Strong buy |
TARSTarsus Pharmaceuticals, Inc. | 2.02 B USD | 52.91 USD | +1.75% | 816.37 K | 1.43 | — | −3.81 USD | +0.54% | 0.00% | Health technology | Strong buy |
AGIOAgios Pharmaceuticals, Inc. | 2.02 B USD | 35.42 USD | −1.09% | 3.2 M | 2.16 | 3.12 | 11.37 USD | — | 0.00% | Health technology | Buy |
MIRMMirum Pharmaceuticals, Inc. | 1.99 B USD | 41.51 USD | +0.92% | 1.19 M | 2.64 | — | −2.07 USD | +52.00% | 0.00% | Health technology | Strong buy |
SUPNSupernus Pharmaceuticals, Inc. | 1.96 B USD | 35.43 USD | −0.95% | 1.06 M | 3.28 | 33.17 | 1.07 USD | +175.07% | 0.00% | Health technology | Buy |
HRMYHarmony Biosciences Holdings, Inc. | 1.96 B USD | 34.28 USD | +1.15% | 2.98 M | 6.33 | 16.23 | 2.11 USD | −14.38% | 0.00% | Health technology | Strong buy |
IRONDisc Medicine, Inc. | 1.92 B USD | 64.50 USD | +2.46% | 441.62 K | 1.54 | — | −3.97 USD | −6.02% | 0.00% | Health technology | Strong buy |
IBRXImmunityBio, Inc. | 1.91 B USD | 2.62 USD | −1.87% | 7.89 M | 0.89 | — | −0.89 USD | +15.29% | 0.00% | Health technology | Buy |
MNKDMannKind Corporation | 1.89 B USD | 6.85 USD | +8.73% | 7.22 M | 2.42 | 97.44 | 0.07 USD | — | 0.00% | Health technology | Strong buy |
AMPHAmphastar Pharmaceuticals, Inc. | 1.88 B USD | 39.14 USD | −0.63% | 2.48 M | 4.34 | 13.02 | 3.01 USD | +17.33% | 0.00% | Health technology | Buy |
ARQTArcutis Biotherapeutics, Inc. | 1.75 B USD | 14.99 USD | +6.24% | 5.22 M | 2.36 | — | −1.79 USD | +59.00% | 0.00% | Health technology | Strong buy |
GLPGGalapagos NV DR | 1.75 B USD | 26.76 USD | +1.48% | 233.1 K | 1.04 | — | — | — | 0.00% | Health technology | Neutral |
FTREFortrea Holdings Inc. | 1.73 B USD | 19.26 USD | +4.11% | 2.65 M | 2.25 | — | −3.14 USD | — | 0.00% | Commercial services | Neutral |
XNCRXencor, Inc. | 1.69 B USD | 24.13 USD | +0.50% | 4.25 M | 6.61 | — | −3.20 USD | −61.20% | 0.00% | Health technology | Strong buy |
DVAXDynavax Technologies Corporation | 1.67 B USD | 12.72 USD | −0.31% | 4.03 M | 2.92 | 97.62 | 0.13 USD | −66.06% | 0.00% | Health technology | Strong buy |
GPCRStructure Therapeutics Inc. DR | 1.6 B USD | 27.90 USD | −6.91% | 1.76 M | 1.56 | — | −2.21 USD | +3.70% | 0.00% | Health technology | Strong buy |